Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
Doxorubicin
TOP2
TOP
9210.121
uM
0.24804
0.37643
-0.9940 -0.9511 2.5542 0.8267
0.9980
0.8970
CAMA-1
HR+
Luminal
Erlotinib
EGFR
ErbB
5912.091
uM
inf
inf
0.9326 0.9326 0.0000 -0.0358
-0.2923
1.0917
CAMA-1
HR+
Luminal
Erlotinib
EGFR
ErbB
5911.09
uM
inf
999.61920
0.7465 -0.0042 0.4153 0.0587
0.7576
1.1067
CAMA-1
HR+
Luminal
Etoposide
TOP2
TOP
5911.074
uM
2.52280
10.37220
-0.3484 -0.6117 0.5652 0.5083
0.9487
1.1317
CAMA-1
HR+
Luminal
Etoposide
TOP2
TOP
5912.074
uM
5.46690
8.61420
-0.5207 -0.5006 1.5256 0.4347
0.9946
0.9249
CAMA-1
HR+
Luminal
Everolimus
MTOR
MTOR
12070.164
uM
0.00797
0.02807
-0.8032 -0.5472 0.5870 0.8995
0.9525
1.2068
CAMA-1
HR+
Luminal
Fascaplysin
CDK4
CDK
5911.084
uM
0.25654
0.35180
-0.9865 -0.9895 3.4566 0.7079
0.9980
1.0262
CAMA-1
HR+
Luminal
Fascaplysin
CDK4
CDK
5912.084
uM
0.26223
0.35486
-0.9745 -0.9787 3.5844 0.6806
0.9984
1.0966
CAMA-1
HR+
Luminal
FR180204
ERK1/2
MAPK
12070.161
uM
inf
inf
0.8208 0.8208 0.0000 0.0972
-0.1231
1.2903
CAMA-1
HR+
Luminal
FR180204
ERK1/2
MAPK
10755.149
uM
inf
inf
0.8927 0.8927 0.0000 0.1628
-0.1038
0.9687
CAMA-1
HR+
Luminal
FR180204
ERK1/2
MAPK
10473.137
uM
inf
inf
0.9840 0.9840 0.0000 0.0297
-0.0565
1.1322
CAMA-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10755.154
uM
inf
inf
0.8328 0.8328 0.0000 0.1445
-0.2770
1.0198
CAMA-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10473.142
uM
inf
inf
0.9428 0.9428 0.0000 0.0415
-0.0641
1.0815
CAMA-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12070.154
uM
inf
inf
0.8347 0.8347 0.0000 0.0945
0.2480
1.1006
CAMA-1
HR+
Luminal
Gefitinib
EGFR
ErbB
9210.024
uM
12.35690
11.57250
0.1404 0.1350 4.8005 0.0791
0.8743
0.8697
CAMA-1
HR+
Luminal
Gefitinib
EGFR
ErbB
7805.016
uM
30.78110
34.5910
0.3689 -0.3932 4.9723 0.0114
0.9712
1.2059
CAMA-1
HR+
Luminal
Geldanamycin
HSP90
HSP90
9210.024
uM
0.02708
0.02780
-0.1680 -0.0321 2.3424 0.6362
0.9731
0.8697
CAMA-1
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
9210.131
uM
inf
inf
0.2276 0.2276 0.0000 0.5616
0.5267
0.9004
CAMA-1
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
9210.011
uM
0.28886
0.05553
0.2266 0.2919 0.5315 0.4188
0.9037
0.9440
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
10755.15
uM
inf
inf
0.4395 0.4395 0.0000 0.2504
0.3664
0.7807
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
10473.138
uM
inf
1.19780
0.7189 0.7475 4.9965 0.0394
0.9219
1.2872
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
12070.16
uM
1.30120
1.15090
0.2168 0.2294 4.9999 0.2666
0.9242
0.8453
CAMA-1
HR+
Luminal
GSK1070916
AURK
AURK
9210.001
uM
8.02190
17.5930
-0.4354 -1.0000 1.3989 0.2132
0.9502
0.8761
CAMA-1
HR+
Luminal
GSK1838705A
IGF1R
RTK
5912.098
uM
inf
inf
0.8785 0.8785 0.0000 0.0261
-0.0048
1.0559
CAMA-1
HR+
Luminal
GSK1838705A
IGF1R
RTK
5911.09
uM
inf
1000.00000
0.7173 0.3149 0.2548 0.0942
0.6346
1.1067